AI in Oncology Market: Global Industry Analysis and Forecast (2025–2032)

The AI in Oncology Market size was valued at USD 1.39 billion in 2024, and the total Revenue is expected to grow at a CAGR of 35.4 % from 2025 to 2032, reaching nearly USD 15.7 billion.
AI in Oncology Market Overview:
The MMR report provides in-depth analysis of the AI in Oncology market by systematically examining economic viability, technological advancement, and real-world adoption. It evaluates pricing models, cost benefits, and return on investment for healthcare providers, while also analyzing innovation pipelines, patent activity, and R&D intensity. The report further assesses adoption levels across regions, clinical workflows, data integration readiness, and hospital infrastructure. it covers patient outcomes, accessibility, investment trends, sustainability considerations, and regulatory and ethical frameworks, offering a well-rounded view of market dynamics and future growth potential.

AI in Oncology as a market is huge, if we consider the current scenario, AI is imprinting its footsteps across every field. Initially, AI was used to detect the cancer cells in tissue samples. But, recent advancements in AI in oncology market have made screening, diagnosis, testing, treatment and monitoring very feasible and effective. Technologies like Deep learning, Natural language processing, AI powered Algorithm, Robotics, etc, has changed the entire dimension of oncology and thus, AI in oncology has huge opportunity to completely revolutionize the market. Nearly 55% of the industry is controlled by North America, while Asia is emerging as a global market leader in oncology market. The recent investments, huge awareness and modern technologies indicate a CAGR OF 35.4%, which is hugely indicating the growth potential and future scope of AI in Oncology market.
To know about the Research Methodology :- Request Free Sample Report
AI in Oncology Market Dynamics
Growth Drivers of AI in Oncology Market

The key drivers for growth are advances in technology which has directly simplified and streamlined many complex processes in the Oncology market. With the advent of digital information, AI has showed promise across all cancer research areas. With the increasing expansion of data sets, molecular-level tumour information from cancer patients can be easily obtained. AI also has made analysing medical images, such as X-rays, CT scans, and MRIs simpler and more accurate. Risk mitigation, Drug testing, Analysis of current and future status of a patient, all has been possible as AI in oncology market has fared well. Also, treatments regarding each patient can be well directed and specialized increasing the chances of cure through such modified treatments. Another driving factor in AI in Oncology market is the use of Machine Learning. These technologies have enhanced robotics in oncology market. Robots can identify data from enormous dataset and recognize specific patterns. This has allowed the creation of advanced robots that can do complicated jobs, which mitigates the risk quotient to a significant limit. Robots can also learn, forecast, and optimise using the data allowing predictive maintenance and quality control. Example – Illumina released Connected Insights to enable tertiary analysis for oncology and uncommon disorders.

Challenges of AI in Oncology market

The major challenge in front of the AI in oncology market is regarding the use of such technologies. The intention behind the use can make the technology regressive or progressive. One such example is of IBM's Watson Oncology, where the AI module was showing non-specific results. Also, cases of failure in deep learning algorithms which misjudged the cancer cells and showed less accurate results has occurred in the past. The data required for these models to function is huge, especially if we talk about more common types of cancers, the dataset becomes huge to analyse. Also, the cost to collect, manage, analyse and derive the data is huge. Another challenge arises when the cancer is of rare type, where on the basis of insufficient data, the model fails to develop a proper treatment. The use of robotics is also questionable especially during direct interference between treatments. The issue of safety, accountability and approval are major challenges of AI in oncology market. Hacking AI systems could provide unauthorised access to patient data or diagnostic outcomes. Thus, tampering with such technologies can be easily possible which can endanger the patient’s life

Trends in AI in Oncology market

The field itself is relatively new and has huge scope in future. AI in oncology market can help with early detection by analysing a patient's medical history and test results to identify patterns that may indicate the presence of cancer. As new drugs are being discovered to cure cancer patients, AI can have a huge role in it. Right from formulation to testing, AI, Robotics, algorithms can play a crucial role in future. Also, AI in oncology market has offered specialists, a more detailed overview, which would eventually make the process even simpler in future. Also, with the advent of AI in oncology market, the implementation of radiation therapy on cancerous cells have changed. Use of AI in radiation therapy has been a huge future implementation of the technology. It can also enhance the quality of radiation therapy by identifying and correcting errors in treatment plans, streamlining the process and making it more efficient
AI in Oncology Market Segment Analysis
Based on the Application, the Diagnostics segment is dominated the AI in Oncology Market in 2024, driven by the widespread adoption of AI-powered imaging, pathology, and early cancer detection tools that improve diagnostic accuracy and reduce turnaround time. Radiation Therapy follows, supported by the use of AI for treatment planning, dose optimization, and precision targeting to enhance clinical outcomes. The Research & Development segment continues to grow steadily as AI accelerates drug discovery, biomarker identification, and clinical trial optimization. Chemotherapy applications are gaining traction through AI-driven treatment planning and response prediction, while Immunotherapy adoption is emerging, driven by AI-based patient stratification and therapy personalization.

Based on the End-user, Hospitals segment is dominated the AI in Oncology Market in 2024, driven by high patient volumes, advanced diagnostic infrastructure, and increasing adoption of AI-enabled imaging, pathology, and clinical decision support systems. Surgical Centers & Medical Institutes follow, supported by growing use of AI for precision surgery planning, treatment optimization, and specialized cancer care. The Others segment, including diagnostic laboratories, research organizations, and specialty clinics, plays a complementary role, primarily focused on niche applications, clinical research, and pilot AI deployments.


AI in Oncology Market Regional Insights
Global
The AI in Oncology market is huge, especially in today’s current scenario where technology has showed its power. The AI in Oncology market is on the verge of becoming the next crucial thing in oncology market. The reason has been technological advancements, huge investments and progressive research into this field. US has been leading the market and has 55% of market share. Asia Pacific is one of the fastest growing markets along with Israel which has established many companies like Ibex Medical Analytics, Nanox, etc helping its share increase in AI in Oncology market.

North America enjoys the highest share of the market, which mainly consist of USA. The strong market presence of key players like Intel Corporation, GE Healthcare has made it sure that the market leader remains constant. The region has advanced laboratory facilities, cutting-edge technologies, and a strong ecosystem of clinicians, researchers, and industry players. Its application use has been one of the best which has helped them sustain the market force. The pre requisite of AI in Oncology market is huge, which makes it possible only for developed and developing countries to proceed in this industry. Canada and Mexico have smaller market share as compared to US but are emerging markets in AI in Oncology industry.

Asia Pacific has been a growing market, especially after huge investments into the AI in Oncology market. China, Japan, India have emerged as leaders in the market. According to the World Health Organization, China had an estimated 3.9 million new cancer cases and 2.3 million cancer deaths in 2020. Thus, China has huge market share of the AI in Oncology industry. The technological prowess which China has, offers more opportunities for China to develop into this market. With India, companies like IBM, Microsoft, Google, NVIDIA, and Amazon Web Services are working on improving research and increase the efficiency. Increase in population and increase in patients both have made sure that the AI in Oncology market increase in Asia Pacific.

Europe is the 2nd largest market of AI in Oncology market. Europe's top research institutions, universities, and hospitals are creating AI-based cancer diagnostic, treatment, and patient care solutions. National healthcare systems in countries like the United Kingdom, Germany, France, and the European countries have allocated funds and resources to promote AI adoption in oncology. The availability of electronic health records and large healthcare databases allows for the utilization of AI algorithms in analysing patient data and developing predictive models for cancer diagnosis and treatment. Companies like Siemens Healthcare GmbH, Sophia Genetics have helped Europe hold on its present and future market share.

MEA has not seen much of a development into the AI in oncology market, but has huge potential in future. Investments into research and adoption of AI has been facilitated by many countries in Middle East and Africa. Saudi Arabia has started many projects and initiatives like KACST - a government-funded research organization that is working to develop AI-based solutions for cancer diagnosis and treatment. Also, collaborations and partnerships have helped Saudi Arabia to gain some market share. The Saudi government has partnered with the United States National Cancer Institute (NCI) to develop an AI-based system for early detection of cancer. Thus, the AI in Oncology market has huge potential but needs to be backed up by right development in research and infrastructure.

The South American market is an emerging industry in AI and Oncology. Several research institutions and universities in South America are actively engaged in AI research for cancer treatment. Brazil has well developed infrastructure but the disparity between south American countries is a major reason for hinderance in its progress. Governments has been spending on research and adoption of AI LIKE FINEP is managed by Brazilian government, MinTIC is funded by Columbian government, FONDEF is funded by Chile government. Thus, such investments have made a difference but a lot of it is required to gain a larger share of AI in Oncology market.
AI in Oncology Market Competitive Landscape
The AI in Oncology market has drawn huge attention from many companies who are willing to invest into these technologies and reap its benefits through its applications. The market has low entry barriers but a lot of financial backing is required to actually scale the product. Many big companies like IBM, Siemens, GE Healthcare have raised huge funds to cater to this dynamic market. AI in Oncology market is dominated by US. Nearly 55% of the market is held by North American companies. Apart from US, Europe has been the 2nd largest market. Germany is the leading country in AI in Oncology market in Europe. Along with Germany, UK and France have also showcased a significant growth in the market. Acquisitions has been common in the industry and one such example is of Merck which acquired Pandion Data to use AI-based solutions and improve the accuracy and efficiency of cancer diagnosis and treatment. Asia Pacific is shown the highest growth in the forecasted period.
AI in Oncology Market Scope: Inquire before buying



Global AI in Oncology Market


Report Coverage
Details


Base Year:
2024
Forecast Period:
2025-2032


Historical Data:
2019 to 2024
Market Size in 2024:
USD 1.39 Bn.


Forecast Period 2025 to 2032 CAGR:
35.4%
Market Size in 2032:
USD 15.7 Bn.


 Segments Covered:
by Component
Software Solutions
Hardware
Services


by Cancer Type
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others


by Deployment Mode
Cloud-Based
On-Premises


by Application
Diagnostics
Radiation Therapy
Research & Development
Chemotherapy
Immunotherapy


by End User
Hospitals
Surgical Centers & Medical Institutes
Others



AI in Oncology Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
AI in Oncology Market, Key Players
The players mentioned are top companies working on AI in Oncology. All these companies have shown tremendous strategy and have huge potential to maximize the potential of AI in Oncology Market.

1. GE HealthCare
2. Siemens Healthineers AG
3. SOPHiA GENETICS
4. IBM Watson Health
5. NVIDIA Corporation
6. Intel Corporation
7. Oracle
8. Philips Healthcare
9. Medtronic plc
10. F. Hoffmann-La Roche Ltd.
11. Varian Medical Systems
12. Elekta AB
13. Tempus Labs Inc.
14. Flatiron Health
15. PathAI Inc.
16. Paige AI
17. ConcertAI
18. Azra AI
19. Digital Diagnostics Inc.
20. Median Technologies
21. Microsoft Corporation
22. Canon Medical Systems
23. Oncora Medical
24. Aidoc
25. iCAD Inc.
26. Lunit Inc.
27. Ibex Medical Analytics
28. Freenome Holdings Inc.
29. Owkin Inc.
30. Proscia Inc.
31. Others

FAQ

1] What segments are covered in the AI in Oncology Market report?
Ans. The segments covered in the AI in Oncology Market report are based on Component, Cancer Type, Deployment Mode, Application, End-User, and region

2] Which region is expected to hold the highest share of the AI in Oncology Market?
Ans. The North America region is expected to hold the highest share of the AI in Oncology Market.

3] What is the market size of the AI in Oncology Market by 2032?
Ans. The market size of the AI in Oncology Market by 2032 is USD 15.7 Bn.

4] What is the growth rate of the AI in Oncology Market?
Ans. The Global AI in Oncology Market is growing at a CAGR of 35.4 % during the forecasting period 2025-2032.

5] What was the market size of the AI in Oncology Market in 2024?
Ans. The market size of the AI in Oncology Market in 2024 was USD 1.39 Bn.